Displaying 12 (all) recruiting clinical trials.
-
A PHASE II PROSPECTIVE TRIAL UTILIZING SHORT COURSE ANDROGEN DEPRIVATION THERAPY IN CONJUNCTION WITH ULTRA-HYPOFRACTIONATED SBRT FOR HIGH RISK NCCN PROSTATE CANCER WITH LOWER RISK ARTERA SCORES
This is a Phase 2 study for patients with high-risk prostate cancer who have Gleason scores of 8–10 or PSA levels between 20 and ...
Phase
Interventional
-
A Phase 1 Trial of JNJ-98768111 an Antibody Drug Conjugate (ADC) Targeting Human Kallikrein-2 (KLK2) for Advanced Prostate Cancer
This Phase 1 study is testing a new drug called JNJ-98768111 in people with metastatic prostate cancer, meaning prostate cancer that has spread to other ...
Phase
Interventional
